Publications by authors named "Jing-Pei Liu"

Claim this Profile
A
ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression.
Jing-Pei Liu, Kuan-Yin Shen, Wei-Chung Cheng, Wei-Chao Chang, Chih-Ying Hsieh, Shih-Jen Liu

Am J Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment.
Sze-Ching Wong, Chun-Chieh Yeh, Xun-Yu Zhang, Chih-Ying Hsieh, Chia-Chien Lo, Jing-Pei Liu

Mol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases.
Cheng-Wei Chou, Yu-Kai Huang, Ting-Ting Kuo, Jing-Pei Liu, Yuh-Pyng Sher

Int J Mol Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT.
Chen-Yuan Lin, Chia-Fong Cho, Shih-Ting Bai, Jing-Pei Liu, Ting-Ting Kuo

Sci Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Changes of erythrocyte rheology in rabbits with acute renal failure].
Guo-Jie Xu, Jing-Pei Liu, Qiang Ji, Jia-Yu Wu, Zeng-Juan Wang

Zhongguo Ying Yong Sheng Li Xue Za Zhi· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection.
Chih-Yu Chi, Chen-Chung Chu, Jing-Pei Liu, Chia-Hao Lin, Mao-Wang Ho

Blood· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis